Journal profile · CRITICAL CARE MEDICINE

Intensive Care Medicine Experimental

ISSN 2197-425X · SpringerOpen · United Kingdom

Intensive Care Medicine Experimental: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.9 (journal website); fully open access; APC about USD 2,990; median 94 days to acceptance (105 articles, last 24 months); 137 articles in 2025; indexed in ESCI and Scopus.

Impact factor2.9From the journal's website, 2025 value
CAS zoneZone 3 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine
Review time94 daysMedian, submission to acceptance · 105 articles, last 24 months · Crossref
APCUSD 2,990Fully open access
Acceptance—No reports yet
Articles per year1372025 · OpenAlex count

Scope

Aims, scope and focus

Intensive Care Medicine Experimental is published by SpringerOpen and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Respiratory Support and Mechanisms, Sepsis Diagnosis and Treatment and Intensive Care Unit Cognitive Disorders, together about 37.6% of its articles. Its main subfields are Critical Care and Intensive Care Medicine. (generated from OpenAlex topic counts and CAS ranking data)

Intensive Care Medicine Experimental (ICMx) is an open access journal specifically dedicated to translational research, aimed at bringing discoveries, potential novel treatments and improved diagnostics closer to the bedside of a critically ill patient. As such, ICMx is uniquely positioned at the intersection of clinical and basic science with a primary focus on the physiology of critical care and emergency medicine. ICMx is intended for all those involved in research aimed at improving emergency care of the critically ill. ICMx aims at publishing research aspiring to: 1) advance understanding of critical illness pathophysiology, 2) support or enhance clinical trial design, 3) test experimental novel treatment interventions, 4) develop or refine experimental models that are relevant to critical care and acute physiologic derangements. ICMx welcomes original studies, reviews, hypothesis papers and state-of-the-art methodology papers. We also encourage correspondence pertinent to the works published in ICMx. Editorial comments will be solicited. ICMx is the official journal of the European Society of Intensive Care Medicine and is dedicated to translational research ICMx is one of few journals publishing research constructing the pipeline of novel discoveries that can advance critical care The board of ICMx represents physiologists, basic scientists dedicated to ICU medicine and ICU physicians, providing an ideal platform to bring discoveries to clinical applications in critical care

From the journal's Aims & Scope

Research area (LetPub): CRITICAL CARE MEDICINE

Editor-in-chief Nicole JuffermansPublisher website

Editorial board by country: none in mainland China; most named Germany 7, Netherlands 5, Switzerland 5, United Kingdom 4, Italy 4 (43 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Respiratory Support and MechanismsMedicine15.1%
  2. Sepsis Diagnosis and TreatmentMedicine14.6%
  3. Intensive Care Unit Cognitive DisordersMedicine7.9%
  4. Cardiac Arrest and ResuscitationMedicine6.6%
  5. Hemodynamic Monitoring and TherapyMedicine6.3%
  6. Immune Response and InflammationImmunology and Microbiology4.4%
  7. Mechanical Circulatory Support DevicesEngineering4.3%
  8. Trauma, Hemostasis, Coagulopathy, ResuscitationMedicine4.2%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorCritical Care MedicineZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorCritical Care MedicineZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

EmbaseCASPublisher website

Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher) 2025
2.9Publisher website ·
5-year impact factor (publisher) 2025
3.1Publisher website ·
CiteScore 2026-06
4.2LetPub ·
SJR 2026-06
0.89LetPub ·
SNIP 2026-06
0.96LetPub ·
h-index
54OpenAlex ·
i10-index
411OpenAlex ·
2-year mean citedness
3.24OpenAlex ·
Self-citation rate
3.4%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
117LetPub ·
Downloads per year (publisher) 2025
1,100,000Publisher website ·

Articles by year OpenAlex count · 2,138 in total · the current year is incomplete

YearArticlesOpen accessCitations
202612912968
2025137137523
2024121121664
202399991,182
20225656765
20216363907

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

94 daysMedian, submission to acceptance · P25–P75 71 days – 133 days

Acceptance to online
median 18 days (105 articles)
Submission to online
median 114 days
Sample
105 articles with submission and acceptance dates (299 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 13 weeksLetPub ·
Submission to first decision
8 daysPublisher website ·
Submission to publication (journal-reported)
about 13 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJEUR 2,490 / USD 2,990 / GBP 2,190YesCC BY
OpenAlexUSD 2,890 / EUR 2,390 / GBP 2,090——
LetPubGBP 1,890 / USD 2,690 / EUR 2,190Yes—
Publisher websiteGBP 2,190 / USD 2,990 / EUR 2,490——

Other charges and waivers (author guidelines)

Other fees
No other fees

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Open calls for papers3, by deadline
  1. Animal Models of Critical Care Illnesses – Current Reality, Future DirectionsDeadline
  2. Sepsis-induced myocardial dysfunction: from mechanisms to precision critical careDeadline
  3. Organ Crosstalk in Critical Illness: Lung, Heart, Kidney and BeyondDeadline
Publisher website
What to prepare2 items from the author guidelines
Suggested reviewers
Optional
Not considered
link to data on a personal/departmental website; individual participant details
Publisher website · model-extracted, each line checked against the text
Article types accepted5
  1. editorial matters arisingFormatting guidelines for specific article types can be found below. Hypothesis Articles Methodologies Research Articles Reviews Editorial Matters ArisingLength not stated
  2. hypothesis articlesFormatting guidelines for specific article types can be found below. Hypothesis Articles Methodologies Research Articles Reviews Editorial Matters ArisingLength not stated
  3. methodologiesFormatting guidelines for specific article types can be found below. Hypothesis Articles Methodologies Research Articles Reviews Editorial Matters ArisingLength not stated
  4. research articlesFormatting guidelines for specific article types can be found below. Hypothesis Articles Methodologies Research Articles Reviews Editorial Matters ArisingLength not stated
  5. reviewsFormatting guidelines for specific article types can be found below. Hypothesis Articles Methodologies Research Articles Reviews Editorial Matters ArisingLength not stated
Publisher website
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
Data availability Formatting the 'Availability of data and materials' section of your manuscript

Data availability: datasets should be deposited in public repositories or included in the paper/supporting files; 'Availability of data and materials' section required. Model summary

The following format for the 'Availability of data and materials section of your manuscript should be used:

Source ↗Publisher website ·
License & copyright Licensing and copyright

Open access articles published under CC BY licence; authors retain copyright. Model summary

Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Intensive Care Medicine Experimental articles are published open access under a CC BY licence (Creative Comm…

Source ↗Publisher website ·
Open access Benefits of open access

Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…

Source ↗Publisher website ·
Peer review Peer review policy

Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
SpringerOpen
Country or region
United Kingdom
Language
English
ISSN
2197-425X
Society / sponsor
European Society of Intensive Care Medicine
Official links

FAQ

Frequently asked questions about Intensive Care Medicine Experimental

What CAS zone is Intensive Care Medicine Experimental in?

In the 2025 upgraded edition of the CAS Journal Ranking, Intensive Care Medicine Experimental is in Zone 3 of Medicine, and in Zone 4 of the minor category Critical Care Medicine. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Intensive Care Medicine Experimental?

The journal's website gives an impact factor of 2.9 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4.2, h-index 54.

How long does peer review take at Intensive Care Medicine Experimental?

Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 94 days (interquartile range 71–133 days); authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Intensive Care Medicine Experimental based?

Of the 43 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Germany (7), Netherlands (5) and Switzerland (5). Counted from the institutions listed on the board page; for reference only.

Which databases index Intensive Care Medicine Experimental?

According to LetPub and DOAJ records, Intensive Care Medicine Experimental is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Embase and CAS; that list has not been checked against each database.

Is Intensive Care Medicine Experimental open access, and what is the APC?

Intensive Care Medicine Experimental is a fully open-access journal. APC about USD 2,990.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .